Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Ins…
Medical - Devices
US, Golden Valley [HQ]
INSP/Financial Reporting
Income Statements
9 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.00 | 16.00 | 28.00 | 50.00 | 82.00 | 115.00 | 233.00 | 407.00 | 624.00 | |
|
EPS
|
-1.71 | -1.49 | -1.30 | -1.50 | -1.40 | -2.19 | -1.54 | -1.60 | -0.72 | |
| Diluted in mil. | -1.71 | -1.49 | -1.30 | -1.50 | -1.40 | -2.19 | -1.54 | -1.60 | -0.72 | |
|
Profit
|
5.00 | 12.00 | 22.00 | 40.00 | 68.00 | 97.00 | 200.00 | 341.00 | 528.00 | |
| Gross Margin | 64.94 | 76.23 | 78.93 | 80.12 | 83.37 | 84.73 | 85.74 | 83.79 | 84.54 | |
| Pre Tax | -21.00 | -18.00 | -17.00 | -21.00 | -33.00 | -57.00 | -41.00 | -44.00 | -19.00 | |
| Profit Margin | -266.31 | -112.79 | -61.30 | -43.14 | -40.47 | -49.48 | -17.98 | -10.85 | -3.19 | |
| ETR | -7.14 | -6.88 | -10.25 | -8.49 | -0.12 | -0.20 | -0.17 | -1.38 | -6.26 | |
| Net | -21.00 | -18.00 | -17.00 | -21.00 | -33.00 | -57.00 | -42.00 | -44.00 | -21.00 | |
| Profit Margin | -266.31 | -112.79 | -61.30 | -43.14 | -40.52 | -49.58 | -18.01 | -11.00 | -3.39 | |
| EBITDA | -19.00 | -17.00 | -15.00 | -18.00 | -31.00 | -54.00 | -39.00 | -42.00 | -40.00 | |
| EBITDA Margin | -245.29 | -104.23 | -54.16 | -36.61 | -37.88 | -47.64 | -17.07 | -10.44 | -6.45 | |
| Operating Income | -19.00 | -17.00 | -16.00 | -20.00 | -34.00 | -56.00 | -39.00 | -47.00 | -40.00 | |
| Operating Margin | -247.10 | -105.03 | -56.02 | -40.28 | -42.53 | -48.72 | -17.07 | -11.67 | -6.45 | |
| Interest Income | - - | - - | - - | 1.00 | 3.00 | 1.00 | - - | 5.00 | 20.00 | |
| Loss | -27.00 | -33.00 | -44.00 | -70.00 | -116.00 | -171.00 | -273.00 | -455.00 | -665.00 | |
| Cost of Revenue | -2.00 | -3.00 | -6.00 | -10.00 | -13.00 | -17.00 | -33.00 | -66.00 | -96.00 | |
|
Operating Expenses
|
-25.00 | -29.00 | -38.00 | -60.00 | -103.00 | -153.00 | -239.00 | -389.00 | -568.00 | |
| R&D | -7.00 | -7.00 | -6.00 | -7.00 | -12.00 | -26.00 | -37.00 | -68.00 | -116.00 | |
| G&A | -2.00 | - - | -3.00 | -53.00 | -72.00 | -101.00 | -154.00 | -246.00 | -351.00 | |
| SG&A | -17.00 | -22.00 | -32.00 | -53.00 | -90.00 | -127.00 | -202.00 | -320.00 | -451.00 | |
| S&M | -15.00 | - - | -28.00 | - - | -18.00 | -26.00 | -47.00 | -74.00 | -100.00 | |
| Depreciation and Amortization | - - | - - | - - | - - | - - | - - | -1.00 | -1.00 | -2.00 | |
| Interest Expenses | -1.00 | -1.00 | -1.00 | -3.00 | -2.00 | -2.00 | -2.00 | -1.00 | - - | |
| Other Expenses | - - | - - | - - | - - | -1.00 | - - | -2.00 | -3.00 | -20.00 | |
|
WA Shares Outstanding
|
12.00 | 12.00 | 13.00 | 14.00 | 23.00 | 26.00 | 27.00 | 28.00 | 29.00 | |
| Diluted | 12.00 | 12.00 | 13.00 | 14.00 | 23.00 | 26.00 | 27.00 | 28.00 | 29.00 |